Mis-splicing of the GALNS gene resulting from deep intronic mutations as a cause of Morquio a disease

Abstract Background Mucopolysaccharidosis-IVA (Morquio A disease) is a lysosomal disorder in which the abnormal accumulation of keratan sulfate and chondroitin-6-sulfate is consequent to mutations in the galactosamine-6-sulfatase (GALNS) gene. Since standard DNA sequencing analysis fails to detect a...

Full description

Bibliographic Details
Main Authors: Anna Caciotti, Rodolfo Tonin, Matthew Mort, David N. Cooper, Serena Gasperini, Miriam Rigoldi, Rossella Parini, Federica Deodato, Roberta Taurisano, Michelina Sibilio, Giancarlo Parenti, Renzo Guerrini, Amelia Morrone
Format: Article
Language:English
Published: BMC 2018-10-01
Series:BMC Medical Genetics
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12881-018-0694-6
_version_ 1819181825106378752
author Anna Caciotti
Rodolfo Tonin
Matthew Mort
David N. Cooper
Serena Gasperini
Miriam Rigoldi
Rossella Parini
Federica Deodato
Roberta Taurisano
Michelina Sibilio
Giancarlo Parenti
Renzo Guerrini
Amelia Morrone
author_facet Anna Caciotti
Rodolfo Tonin
Matthew Mort
David N. Cooper
Serena Gasperini
Miriam Rigoldi
Rossella Parini
Federica Deodato
Roberta Taurisano
Michelina Sibilio
Giancarlo Parenti
Renzo Guerrini
Amelia Morrone
author_sort Anna Caciotti
collection DOAJ
description Abstract Background Mucopolysaccharidosis-IVA (Morquio A disease) is a lysosomal disorder in which the abnormal accumulation of keratan sulfate and chondroitin-6-sulfate is consequent to mutations in the galactosamine-6-sulfatase (GALNS) gene. Since standard DNA sequencing analysis fails to detect about 16% of GALNS mutant alleles, gross DNA rearrangement screening and uniparental disomy evaluation are required to complete the molecular diagnosis. Despite this, the second pathogenic GALNS allele generally remains unidentified in ~ 5% of Morquio-A disease patients. Methods In an attempt to bridge the residual gap between clinical and molecular diagnosis, we performed an mRNA-based evaluation of three Morquio-A disease patients in whom the second mutant GALNS allele had not been identified. We also performed sequence analysis of the entire GALNS gene in two patients. Results Different aberrant GALNS mRNA transcripts were characterized in each patient. Analysis of these transcripts then allowed the identification, in one patient, of a disease-causing deep intronic GALNS mutation. The aberrant mRNA products identified in the other two individuals resulted in partial exon loss. Despite sequencing the entire GALNS gene region in these patients, the identity of a single underlying pathological lesion could not be unequivocally determined. We postulate that a combination of multiple variants, acting in cis, may synergise in terms of their impact on the splicing machinery. Conclusions We have identified GALNS variants located within deep intronic regions that have the potential to impact splicing. These findings have prompted us to incorporate mRNA analysis into our diagnostic flow procedure for the molecular analysis of Morquio A disease.
first_indexed 2024-12-22T22:36:23Z
format Article
id doaj.art-dc37d65579c440fe8a8fdf055c411622
institution Directory Open Access Journal
issn 1471-2350
language English
last_indexed 2024-12-22T22:36:23Z
publishDate 2018-10-01
publisher BMC
record_format Article
series BMC Medical Genetics
spelling doaj.art-dc37d65579c440fe8a8fdf055c4116222022-12-21T18:10:17ZengBMCBMC Medical Genetics1471-23502018-10-011911910.1186/s12881-018-0694-6Mis-splicing of the GALNS gene resulting from deep intronic mutations as a cause of Morquio a diseaseAnna Caciotti0Rodolfo Tonin1Matthew Mort2David N. Cooper3Serena Gasperini4Miriam Rigoldi5Rossella Parini6Federica Deodato7Roberta Taurisano8Michelina Sibilio9Giancarlo Parenti10Renzo Guerrini11Amelia Morrone12Molecular and Cell Biology Laboratory of Neurometabolic Diseases, Paediatric Neurology Unit and Laboratories, Neuroscience Department, Meyer Children’s HospitalMolecular and Cell Biology Laboratory of Neurometabolic Diseases, Paediatric Neurology Unit and Laboratories, Neuroscience Department, Meyer Children’s HospitalInstitute of Medical Genetics, School of Medicine, Cardiff UniversityInstitute of Medical Genetics, School of Medicine, Cardiff UniversityMetabolic Unit, San Gerardo HospitalMetabolic Unit, San Gerardo HospitalMetabolic Unit, San Gerardo HospitalDivision of Metabolism, Bambino Gesù Children’s Hospital, IRCCSDivision of Metabolism, Bambino Gesù Children’s Hospital, IRCCSDepartment of Translational Medical Sciences, Section of Pediatrics, Federico II University of NaplesDepartment of Translational Medical Sciences, Section of Pediatrics, Federico II University of NaplesMolecular and Cell Biology Laboratory of Neurometabolic Diseases, Paediatric Neurology Unit and Laboratories, Neuroscience Department, Meyer Children’s HospitalMolecular and Cell Biology Laboratory of Neurometabolic Diseases, Paediatric Neurology Unit and Laboratories, Neuroscience Department, Meyer Children’s HospitalAbstract Background Mucopolysaccharidosis-IVA (Morquio A disease) is a lysosomal disorder in which the abnormal accumulation of keratan sulfate and chondroitin-6-sulfate is consequent to mutations in the galactosamine-6-sulfatase (GALNS) gene. Since standard DNA sequencing analysis fails to detect about 16% of GALNS mutant alleles, gross DNA rearrangement screening and uniparental disomy evaluation are required to complete the molecular diagnosis. Despite this, the second pathogenic GALNS allele generally remains unidentified in ~ 5% of Morquio-A disease patients. Methods In an attempt to bridge the residual gap between clinical and molecular diagnosis, we performed an mRNA-based evaluation of three Morquio-A disease patients in whom the second mutant GALNS allele had not been identified. We also performed sequence analysis of the entire GALNS gene in two patients. Results Different aberrant GALNS mRNA transcripts were characterized in each patient. Analysis of these transcripts then allowed the identification, in one patient, of a disease-causing deep intronic GALNS mutation. The aberrant mRNA products identified in the other two individuals resulted in partial exon loss. Despite sequencing the entire GALNS gene region in these patients, the identity of a single underlying pathological lesion could not be unequivocally determined. We postulate that a combination of multiple variants, acting in cis, may synergise in terms of their impact on the splicing machinery. Conclusions We have identified GALNS variants located within deep intronic regions that have the potential to impact splicing. These findings have prompted us to incorporate mRNA analysis into our diagnostic flow procedure for the molecular analysis of Morquio A disease.http://link.springer.com/article/10.1186/s12881-018-0694-6GALNSMorquio a diseaseMucopolysaccharidosis IVADeep intronic mutationsmRNA defectsWhole gene sequencing
spellingShingle Anna Caciotti
Rodolfo Tonin
Matthew Mort
David N. Cooper
Serena Gasperini
Miriam Rigoldi
Rossella Parini
Federica Deodato
Roberta Taurisano
Michelina Sibilio
Giancarlo Parenti
Renzo Guerrini
Amelia Morrone
Mis-splicing of the GALNS gene resulting from deep intronic mutations as a cause of Morquio a disease
BMC Medical Genetics
GALNS
Morquio a disease
Mucopolysaccharidosis IVA
Deep intronic mutations
mRNA defects
Whole gene sequencing
title Mis-splicing of the GALNS gene resulting from deep intronic mutations as a cause of Morquio a disease
title_full Mis-splicing of the GALNS gene resulting from deep intronic mutations as a cause of Morquio a disease
title_fullStr Mis-splicing of the GALNS gene resulting from deep intronic mutations as a cause of Morquio a disease
title_full_unstemmed Mis-splicing of the GALNS gene resulting from deep intronic mutations as a cause of Morquio a disease
title_short Mis-splicing of the GALNS gene resulting from deep intronic mutations as a cause of Morquio a disease
title_sort mis splicing of the galns gene resulting from deep intronic mutations as a cause of morquio a disease
topic GALNS
Morquio a disease
Mucopolysaccharidosis IVA
Deep intronic mutations
mRNA defects
Whole gene sequencing
url http://link.springer.com/article/10.1186/s12881-018-0694-6
work_keys_str_mv AT annacaciotti missplicingofthegalnsgeneresultingfromdeepintronicmutationsasacauseofmorquioadisease
AT rodolfotonin missplicingofthegalnsgeneresultingfromdeepintronicmutationsasacauseofmorquioadisease
AT matthewmort missplicingofthegalnsgeneresultingfromdeepintronicmutationsasacauseofmorquioadisease
AT davidncooper missplicingofthegalnsgeneresultingfromdeepintronicmutationsasacauseofmorquioadisease
AT serenagasperini missplicingofthegalnsgeneresultingfromdeepintronicmutationsasacauseofmorquioadisease
AT miriamrigoldi missplicingofthegalnsgeneresultingfromdeepintronicmutationsasacauseofmorquioadisease
AT rossellaparini missplicingofthegalnsgeneresultingfromdeepintronicmutationsasacauseofmorquioadisease
AT federicadeodato missplicingofthegalnsgeneresultingfromdeepintronicmutationsasacauseofmorquioadisease
AT robertataurisano missplicingofthegalnsgeneresultingfromdeepintronicmutationsasacauseofmorquioadisease
AT michelinasibilio missplicingofthegalnsgeneresultingfromdeepintronicmutationsasacauseofmorquioadisease
AT giancarloparenti missplicingofthegalnsgeneresultingfromdeepintronicmutationsasacauseofmorquioadisease
AT renzoguerrini missplicingofthegalnsgeneresultingfromdeepintronicmutationsasacauseofmorquioadisease
AT ameliamorrone missplicingofthegalnsgeneresultingfromdeepintronicmutationsasacauseofmorquioadisease